Auxilium Pharma (AUXL) Posts Q3 loss of $0.34
AUXL Hot Sheet
Revenue Growth %: +26.0%Financial Fact:
Total operating expenses: 75.54M
Today's EPS Names:
BRLI, TLB, TNP, More
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reports Q3 loss of $0.34, versus the analyst estimate of ($0.31). Revenue for the quarter was $42.10 million, which compares to the estimate of $41.23 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Watson Pharma (WPI) Confirms Patent Challenge on Testim from Auxilium
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
